Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. (MDNA.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDNA.TO · as of Jun 8, 2026
Key Statistics
Explore Medicenna Therapeutics Corp. Data
mdna.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
mdna.to competitorsMDNA.TO
ARCH.V
BNXT.CN
COV.V
DTC.CN
MDP.TOStock Performance
Full HistoryAbout Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead…
what is medicenna therapeutics corp. · mdna.to stock overview · medicenna therapeutics corp. company profile · who is medicenna therapeutics corp. ceo · mdna.to TSX · medicenna therapeutics corp. headquarters · medicenna therapeutics corp. business segments
About Stock Overview & Key Data
Medicenna Therapeutics Corp. (MDNA.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Mar 8, 2017. As of the latest trading session, MDNA.TO stock price is $0.45, with a market capitalization of $30.9M. The stock has returned -50.55% over the past 12 months and -51.09% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Medicenna Therapeutics Corp. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Medicenna Therapeutics Corp. reported revenue of — and net income of -$11.8M. For detailed data — including Medicenna Therapeutics Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medicenna Therapeutics Corp. (MDNA.TO) stock price is $0.45. The stock is traded on TSX under the ticker symbol MDNA.TO. The 52-week range is $0.41 – $1.97.